Compare Deltanoid Pharmaceuticals vs Mast Therapeutics
Customers evaluate the quality of Deltanoid Pharmaceuticals's products using the following success metrics.
Overview
Deltanoid Pharmaceuticals is 23 yrs old and is based in United States.
Deltanoid Pharmaceuticals is a clinical stage biopharmaceutical company with a vision focused on unlocking the power of the vitamin D receptor (VDR) to transform health outcomes for patients with diseases of the kidney, bone, and skin.
Mast Therapeutics is 29 yrs old and is based in United States.
Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer. Mast's lead product candidate, AIR001, is a sodium nitrite solution for intermittent inhalation via nebulization in Phase 2 clinical development for the treatment of HFpEF.
Demo Video
Leadership
Carrie McQueen (Chief Financial Officer)
Funding
Investors
Venture Investors, Wisconsin Alumni Research Foundation
Savara, Centrum Bank AG
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Deltanoid Pharmaceuticals has not claimed their profile.
Work for Deltanoid Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Deltanoid Pharmaceuticals?
Claim your profile now.
Information not available because Mast Therapeutics has not claimed their profile.
Work for Mast Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Mast Therapeutics?
Claim your profile now.